生物活性 | |||
---|---|---|---|
描述 | Brimonidine tartrate is a α2 adrenergic agonist and hydrophilic drug used for treatment of glaucoma. BRT-loaded (Brimonidine Tartarate) proniosomal gels showed an improved ocular bioavailability and sustained drug release from the prepared vesicles[3]. Clinical trials have demonstrated that brimonidine tartrate provided significantly greater efficacy, compared to vehicle, for the treatment of moderate to severe erythema of rosacea[4]. At a concentration of 0.1 µM or higher, brimonidine increased survival of purified rat RGCs (retinal ganglion cells) in the presence of glutamate neurotoxicity, oxidative stress, and hypoxia [5]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.26mL 0.45mL 0.23mL |
11.31mL 2.26mL 1.13mL |
22.61mL 4.52mL 2.26mL |
参考文献 |
---|